Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 3 | 2019 | 199 | 0.810 |
Why?
|
| Rhizopus | 1 | 2019 | 1 | 0.630 |
Why?
|
| Xylose | 1 | 2019 | 12 | 0.630 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2019 | 64 | 0.620 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 98 | 0.600 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2019 | 110 | 0.590 |
Why?
|
| Lactic Acid | 1 | 2019 | 110 | 0.590 |
Why?
|
| Prostatic Neoplasms | 8 | 2014 | 1068 | 0.440 |
Why?
|
| Poliovirus Vaccines | 1 | 2012 | 2 | 0.400 |
Why?
|
| Chemokine CXCL10 | 1 | 2012 | 38 | 0.380 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 62 | 0.370 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 80 | 0.370 |
Why?
|
| Hela Cells | 1 | 2012 | 370 | 0.360 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2010 | 39 | 0.340 |
Why?
|
| Fermentation | 3 | 2019 | 38 | 0.320 |
Why?
|
| Universities | 2 | 2012 | 539 | 0.310 |
Why?
|
| Peptides | 1 | 2012 | 357 | 0.310 |
Why?
|
| Peptide Fragments | 1 | 2010 | 301 | 0.290 |
Why?
|
| Ethanol | 3 | 2019 | 221 | 0.280 |
Why?
|
| Biomedical Research | 1 | 2012 | 467 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 979 | 0.200 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2002 | 8 | 0.190 |
Why?
|
| Synaptic Vesicles | 1 | 2002 | 31 | 0.180 |
Why?
|
| Fungal Proteins | 2 | 2019 | 143 | 0.180 |
Why?
|
| Crotonates | 1 | 2021 | 1 | 0.180 |
Why?
|
| Toluidines | 1 | 2021 | 3 | 0.180 |
Why?
|
| Hydroxybutyrates | 1 | 2021 | 3 | 0.180 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 2021 | 13 | 0.180 |
Why?
|
| Nitriles | 1 | 2021 | 78 | 0.170 |
Why?
|
| Quercetin | 2 | 2012 | 46 | 0.170 |
Why?
|
| Cell Movement | 3 | 2012 | 640 | 0.160 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2019 | 11 | 0.160 |
Why?
|
| Adenocarcinoma | 3 | 2010 | 287 | 0.160 |
Why?
|
| Symporters | 1 | 2019 | 15 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 246 | 0.160 |
Why?
|
| Prostate | 2 | 2010 | 152 | 0.150 |
Why?
|
| Transgenes | 1 | 2019 | 65 | 0.150 |
Why?
|
| Sequence Deletion | 1 | 2019 | 92 | 0.150 |
Why?
|
| DNA Damage | 2 | 2012 | 358 | 0.150 |
Why?
|
| Glucosides | 1 | 2018 | 21 | 0.150 |
Why?
|
| Cellulose | 1 | 2018 | 23 | 0.150 |
Why?
|
| Cell Proliferation | 6 | 2021 | 1420 | 0.140 |
Why?
|
| Glucose | 1 | 2019 | 242 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2016 | 462 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 452 | 0.140 |
Why?
|
| Lactose | 1 | 2016 | 16 | 0.130 |
Why?
|
| Gene Expression | 1 | 2019 | 692 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2014 | 501 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1112 | 0.120 |
Why?
|
| Cell Line, Tumor | 6 | 2014 | 2598 | 0.120 |
Why?
|
| Alabama | 2 | 2012 | 52 | 0.120 |
Why?
|
| Protein Binding | 2 | 2012 | 1076 | 0.110 |
Why?
|
| Humans | 15 | 2021 | 42163 | 0.110 |
Why?
|
| Interinstitutional Relations | 2 | 2013 | 51 | 0.110 |
Why?
|
| Regional Health Planning | 1 | 2013 | 14 | 0.110 |
Why?
|
| Minority Health | 1 | 2013 | 96 | 0.100 |
Why?
|
| Poliomyelitis | 1 | 2012 | 7 | 0.100 |
Why?
|
| Receptors, CXCR3 | 1 | 2012 | 31 | 0.100 |
Why?
|
| Neoplasms | 3 | 2013 | 1341 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2012 | 124 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 74 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2012 | 348 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2012 | 135 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 118 | 0.090 |
Why?
|
| Ruta | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2012 | 383 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2010 | 105 | 0.080 |
Why?
|
| Ethics, Research | 1 | 2010 | 18 | 0.080 |
Why?
|
| Nocodazole | 1 | 2010 | 8 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2010 | 18 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 209 | 0.080 |
Why?
|
| Health Status Disparities | 2 | 2013 | 705 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1188 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2010 | 64 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1559 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2012 | 324 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2012 | 502 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 297 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 875 | 0.070 |
Why?
|
| Male | 9 | 2021 | 22779 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 680 | 0.070 |
Why?
|
| Communication | 1 | 2010 | 207 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 573 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 250 | 0.070 |
Why?
|
| Antioxidants | 1 | 2012 | 439 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 273 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 134 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 933 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2012 | 722 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2011 | 303 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2010 | 426 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2021 | 1265 | 0.060 |
Why?
|
| Apoptosis | 2 | 2012 | 1541 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2012 | 2111 | 0.060 |
Why?
|
| Cell Line | 2 | 2010 | 1416 | 0.050 |
Why?
|
| Cell Survival | 2 | 2021 | 934 | 0.050 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2002 | 2 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2002 | 20 | 0.050 |
Why?
|
| Synaptosomes | 1 | 2002 | 22 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 95 | 0.050 |
Why?
|
| Exocytosis | 1 | 2002 | 49 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2002 | 47 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2002 | 140 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2012 | 32 | 0.040 |
Why?
|
| Gene Products, tax | 1 | 2021 | 4 | 0.040 |
Why?
|
| HTLV-I Infections | 1 | 2021 | 33 | 0.040 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2021 | 35 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 124 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2002 | 156 | 0.040 |
Why?
|
| Cyclin B1 | 2 | 2012 | 18 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 284 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2002 | 131 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 91 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2012 | 411 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 11819 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 318 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 658 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 7982 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 382 | 0.040 |
Why?
|
| Calcium | 1 | 2002 | 487 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 884 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2002 | 973 | 0.040 |
Why?
|
| Neurospora crassa | 1 | 2018 | 10 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 233 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 111 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2002 | 548 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 522 | 0.030 |
Why?
|
| Cellobiose | 1 | 2016 | 1 | 0.030 |
Why?
|
| beta-Glucosidase | 1 | 2016 | 6 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 37 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 37 | 0.030 |
Why?
|
| Mice | 2 | 2010 | 6490 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2013 | 58 | 0.030 |
Why?
|
| Brain | 1 | 2002 | 1452 | 0.030 |
Why?
|
| Community Networks | 1 | 2013 | 106 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 69 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 79 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 81 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 180 | 0.020 |
Why?
|
| Etoposide | 1 | 2012 | 21 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 24 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 56 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2012 | 34 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 102 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 76 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 46 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 295 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 189 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 5 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 13458 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 92 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 196 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 158 | 0.020 |
Why?
|
| Morals | 1 | 2010 | 15 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 60 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 683 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 16695 | 0.020 |
Why?
|
| Food-Drug Interactions | 1 | 2010 | 4 | 0.020 |
Why?
|
| Androgens | 1 | 2010 | 107 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 226 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 53 | 0.020 |
Why?
|
| G2 Phase | 1 | 2010 | 29 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 151 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 661 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 506 | 0.020 |
Why?
|
| Tubulin | 1 | 2010 | 94 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2013 | 1376 | 0.020 |
Why?
|
| Microtubules | 1 | 2010 | 120 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 237 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2010 | 208 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 290 | 0.020 |
Why?
|
| Female | 2 | 2021 | 24018 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 1848 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2803 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4936 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1679 | 0.010 |
Why?
|